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Hypospadias is a male birth defect in which the
urethral orifice is abnormally located on the
ventral side of the penis. In Western countries,
the prevalence of hypospadias varies from 2 to
8 cases per 1,000 live births, with increases in
prevalence reported over time in several popula-
tions (Czeizel et al. 1986; Kallen and Winberg
1982; Nelson et al. 2005; Paulozzi 1999;
Paulozzi et al. 1997; Pierik et al. 2002).
Although we know that urethral development,
occurring during gestational weeks 7–16, is reg-
ulated by androgens, the causes of most
hypospadias cases are unknown (Baskin and
Ebbers 2006). Hypospadias is only rarely a
monogenic trait (Fredell et al. 2002). Several
gene defects, including defects in genes coding
for the androgen receptor, are associated with
hypospadias but account for only a small pro-
portion of cases (Nelson et al. 2005).
Reported associations between hypospadias
and low birth weight, preterm birth, and signs
of preeclampsia (Akre et al. 1999; Aschim et al.
2004; Boisen et al. 2005; Hussain et al. 2002;
Main et al. 2006) indicate that placental mal-
function and subsequent abnormalities in hor-
mone regulation and/or the provision of
nutrients to the fetus may play a role in the
maldevelopment of the urethra. Increases in
prevalence, as reported by several investigators
(Paulozzi 1999; Paulozzi et al. 1997; Pierik
et al. 2002; Toppari et al. 2001), also point to
the involvement of environmental determi-
nants. To date, only a few studies have reported
positive associations between hypospadias and
environmental exposures, but reports of links
with prenatal exposure to diethylstilbestrol
(Brouwers et al. 2006; Klip et al. 2002) and
exogenous progestins (Carmichael et al.
2005a), as well as of increased risk associated
with maternal vegetarian diet (North and
Golding 2000), are of interest. With the results
of these previous studies in mind, in the present
case–control study we investigated the relation-
ships between hypospadias risk and maternal
diet, exposure to exogenous hormones, and
exposures thought to reﬂect placental function.
Methods
The data for this study were collected as part
of a joint Danish–Swedish case–control study
of both hypospadias and cryptorchidism.
Virtually identical questionnaires were used
in the two countries to collect exposure infor-
mation from the mothers of cases and con-
trols. However, case ascertainment and
control selection differed in Denmark and
Sweden; consequently, we describe study sub-
ject recruitment separately for each country.
The study complied with all applicable
international regulations and was approved
by ethical review boards in both Sweden and
Denmark, and the subjects gave informed
consent before the study.
Recruitment of hypospadias cases and
controls: Sweden. Each Swedish administrative
region has a single pediatric surgery clinic to
which all hypospadias cases are referred upon
discovery. We recruited hypospadias cases
without concomitant malformations or chro-
mosomal abnormalities from the clinics at
Karolinska University Hospital (Stockholm)
and Uppsala Academic Hospital, which
together serve a population with almost 50,000
live births per year. We invited mothers of boys
with a hypospadias diagnosis, conﬁrmed by a
pediatric urologist in the periods March 2000
through September 2001 and September 2003
through March 2005, to participate in our
case–control study; 204 (95%) of 214 women
accepted the invitation. These 214 cases corre-
spond to an approximate prevalence at birth of
0.0015. Although the estimated prevalence at
birth of hypospadias in Sweden is 0.0033, our
case detection rate seems reasonable, because
we restricted the study to isolated malforma-
tions that were discovered at an early age.
Participating mothers completed a self-admin-
istered questionnaire (see below) during the
clinic visit at which they were recruited into the
study. A study coordinator was available at that
time to answer any questions the mothers had
about the questionnaire but was otherwise
uninvolved in its administration.
For each hypospadias case, we randomly
selected one or two control boys without
known malformations or chromosomal abnor-
malities from the Swedish Medical Birth
Register (one control per case during the ﬁrst
half of the study, and two controls per case
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BACKGROUND: An increase in the prevalence of hypospadias has been reported, but the environ-
mental causes remain virtually unknown.
OBJECTIVES: Our goal was to assess the association between risk of hypospadias and indicators of
placental function and endogenous hormone levels, exposure to exogenous hormones, maternal diet
during pregnancy, and other environmental factors.
METHODS: We conducted a case–control study in Sweden and Denmark from 2000 through 2005
using self-administered questionnaires completed by mothers of hypospadias cases and matched
controls. The response rate was 88% and 81% among mothers of cases and controls, respectively.
The analyses included 292 cases and 427 controls.
RESULTS: A diet during pregnancy lacking both fish and meat was associated with a more than
4-fold increased risk of hypospadias [odds ratio (OR) = 4.6; 95% confidence interval (CI),
1.6–13.3]. Boys born to obese [body mass index (BMI) ≥ 30] women had a more than 2-fold
increased risk of hypospadias (OR = 2.6; 95% CI, 1.2–5.7) compared with boys born to mothers
with a normal weight (BMI = 20–24). Maternal hypertension during pregnancy and absence of
maternal nausea increased a boy’s risk of hypospadias 2.0-fold (95% CI, 1.1–3.7) and 1.8-fold
(95% CI, 1.2–2.8), respectively. Nausea in late pregnancy also appeared to be positively associated
with hypospadias risk (OR = 7.6; 95% CI, 1.1–53).
CONCLUSIONS: A pregnancy diet lacking meat and ﬁsh appears to increase the risk of hypospadias
in the offspring. Other risk associations were compatible with a role for placental insufﬁciency in
the etiology of hypospadias.
KEY WORDS: birth weight, body mass index, diet, hypertension, hypospadias, pregnancy, risk. Environ
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[Online 9 April 2008]during the second half), born within 6 months
of and in the same county as the case. We
obtained their addresses from the Swedish Tax
Authority’s Population Register (Statistics
Sweden, Örebro, Sweden; http://www.scb.se)
and mailed an information packet and a ques-
tionnaire to each control’s mother. Shortly
thereafter, we contacted the women by phone
to encourage participation and answer any
questions. Of 421 approached control mothers,
353 (84%) returned a completed questionnaire.
In Sweden, the median age of the son when
his mother completed the questionnaire was
2 months (range, 0–6 months) for cases and
5 months (range, 1–9 months) for controls.
Recruitment of hypospadias cases and con-
trols: Denmark. Subjects from the Danish
National Birth Cohort. The Danish National
Birth Cohort (DNBC) is a population-based
cohort of Danish women and children estab-
lished to allow investigation of the impact of a
wide range of in utero exposures on health over
the life course (Olsen et al. 2001). More than
101,000 pregnant women recruited during
1996–2002 gave birth to nearly 94,000 chil-
dren between 1997 and 2003. The women
were interviewed twice while pregnant and
twice after delivery. For boys, the ﬁrst postpar-
tum interview, which occurred when the infant
was approximately 6 months of age, included
questions about hypospadias as well as other
birth defects and chromosomal abnormalities.
Within 1 month of the interview, we
mailed study materials to DNBC mothers
who had their first postpartum interview
between December 2000 and February 2003
and responded that their son had been diag-
nosed with hypospadias, but not with Down
syndrome, cleft lip and/or palate, or cryp-
torchidism. We then contacted them by
phone to ask them to participate in our study.
We confirmed the diagnosis of hypospadias
by the mother’s response to the following spe-
cific question in our exposure-measurement
questionnaire: Has a doctor stated that your
son’s urethral oriﬁce is aberrantly located on
the underside of his penis (the condition is
also called hypospadias)?
For each case, we randomly selected two
controls boys from DNBC cohort boys meet-
ing the following criteria: a) never diagnosed
with hypospadias, cryptorchidism, Down syn-
drome, or cleft lip/palate (according to infor-
mation provided by their mothers in the ﬁrst
DNBC postpartum interview); b) born in the
same county as the case; and c) born within
2 weeks (maximum) of the case. As with case
mothers, we mailed study materials to control
mothers within 1 month of the DNBC inter-
view and then contacted them by phone.
Subjects from the Danish national regis-
ters. To increase the power of our study, we
recruited additional cases and controls through
the National Patient Register and the Medical
Birth Register (National Board of Health,
Copenhagen; http://www.sst.dk). The National
Patient Register contains all discharge diagnoses
for inpatients discharged from Danish hospi-
tals, as well as all diagnoses associated with hos-
pital outpatient visits. The Medical Birth
Register contains information on all births
occurring in Denmark. Both registers contain
mandatorily reportable information, are
updated daily, and are considered close to com-
plete. We obtained information on newly regis-
tered cases of hypospadias [International
Classiﬁcation of Diseases, 10th Revision (ICD-
10), codes Q54.0–Q54.9 (World Health
Organization 1993)] in boys < 6 months of age
from the National Patient Register every
3 months between December 2001 and
February 2003. We mailed study materials to
mothers of cases without concomitant Down
syndrome, cleft lip and/or palate, or cryp-
torchidism, and then contacted them by phone
and asked them to participate in our study.
For each case, we selected one control boy
at random from the boys listed in the Medical
Birth Register as being born in the same
county and calendar month as the case. We
used information from the National Patient
Register to confirm that controls had never
been diagnosed with hypospadias, cryp-
torchidism, Down syndrome, or cleft lip
and/or palate. We contacted mothers of con-
trol boys in the same way as case mothers.
In total, 138 (80%) of 173 case mothers
we contacted in Denmark and 182 (75%) of
243 invited controls returned a completed
questionnaire. Forty-one (30%) of the cases
and 52 (29%) of the controls in Denmark
came from the DNBC. The median age in
Denmark of the son when his mother com-
pleted the questionnaire was 5 months (range,
1–8 months) for cases and 6 months (range,
2–7 months) for controls.
Collection of exposure data. Each mother
completed a self-administered questionnaire
that included questions about her gynecologic
and reproductive history, her health and diet
before and during the index pregnancy, and
her smoking habits while pregnant, as well as
parental demographic, physical, and social
characteristics and characteristics of the
case/control boy. We received completed
questionnaires for 342 cases and 535 controls.
Apart from a few extra questions in the
Danish questionnaire regarding the ascertain-
ment of hypospadias, the questionnaires used
in Sweden and Denmark were identical.
For most questions, the questionnaire pro-
vided two or more choices of response. Some
of the less intuitive questions are described
here. We assessed irregular menstrual periods
by asking whether the mother always had regu-
lar periods (yes/no). In the question about
menstrual cycle length, we gave different inter-
vals; possible responses also included unknown
cycle length and irregular periods. We assessed
contraceptive use at conception by listing seven
types of contraception: combined oral contra-
ceptives, minipills, injections, implants,
intrauterine device (IUD), IUD with hor-
mones, and other methods such as condom
and natural methods. We ascertained history of
complications such as high blood pressure and
proteinuria with yes/no questions. In the ques-
tion regarding nausea during pregnancy, we
asked those who stated that they had been nau-
seous to specify the trimester of nausea, and
permitted them to specify more than one
trimester. We assessed meat consumption by
asking whether meat had been consumed at
least once a week, whereas the consumption of
ﬁsh we further categorized into less than once
weekly, once or twice, three or four times, and
more than four times weekly. Because of a
paucity of mothers in the highest category,
however, we collapsed the top two categories.
Statistical analyses. Exclusions. In our
questionnaire, we asked mothers of boys
recruited from the DNBC to confirm that
their sons had (cases) or did not have (con-
trols) hypospadias. We also asked them to
confirm that their sons did not have cryp-
torchidism. We excluded cases from the analy-
sis if a) their mothers did not answer the
hypospadias question (n = 10) or denied that
their sons had hypospadias (n = 3), and no
hypospadias diagnosis code was registered in
the National Patient Register; b) information
on cryptorchidism status was missing (n = 3);
or c) they were reported to have cryp-
torchidism (n = 5). We excluded controls if
a) information on hypospadias (n = 4) or cryp-
torchidism (n = 5) was missing, b) their moth-
ers claimed they had hypospadias (n = 1), or
c) they were reported to have cryptorchidism
(n = 4). After exclusion, 321 cases and
522 controls remained for analysis.
Modeling strategy. We performed analyses
using Intercooled Stata 8.1 for Microsoft
Windows (StataCorp., College Station, TX,
USA) and SAS software (version 9.1; SAS
Institute Inc., Cary, NC, USA). We estimated
odds ratios (ORs) and 95% conﬁdence inter-
vals (CIs) using conditional logistic regression,
taking into account the matched design; 291
strata (291 cases, 427 controls) had complete
information and were included in the analyses.
Variables that were associated with the outcome
in univariate analyses or that we regarded as
potential confounders (e.g., maternal age,
weight for gestational age, gestational age) we
considered in multivariable models. Variables
that were not associated with the outcome in
multivariable analyses and whose withdrawal
from the model did not change the OR esti-
mate for at least one other variable in the model
by ≥ 10% we did not retain in the ﬁnal multi-
variable model. Variables that did not meet the
criteria for inclusion in the multivariable model
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traceptive use at conception, maternal smoking
in the first trimester) we added to the final
model individually for evaluation in the multi-
variable setting.
Swedish hypospadias cases recruited by
the Stockholm clinic (n = 156) were catego-
rized according to severity by a single pedi-
atric urologist (A.N.). To investigate the
effects of our exposure variables in the most
severely affected group of hypospadias cases
possible, we repeated the analyses restricted to
more severe cases from this clinic (n = 77) and
their matched controls. We defined “severe”
hypospadias in this case as having the urethral
oriﬁce proximal to the glandular corona.
Results
Table 1 presents variable distributions for
cases and controls, along with unadjusted
ORs and 95% CIs, for selected study vari-
ables. In the univariate analyses, we found the
following variables to be positively associated
with risk of hypospadias: low maternal age,
high maternal body mass index (BMI), low
maternal education, pregnancy hypertension,
proteinuria during pregnancy, lack of nausea
during pregnancy, no meat consumption dur-
ing pregnancy, no or low intake of ﬁsh during
pregnancy, maternal passive smoking during
pregnancy, low birth weight, low gestational
age at birth, and neonatal jaundice (Table 1).
Use of nonhormonal forms of contraception
at the time of conception was negatively asso-
ciated with hypospadias risk (Table 1).
In the multivariable analyses, the associa-
tion with nonhormonal contraceptive use
remained, although with wider CIs that
included the null (Table 2). Likewise, mater-
nal age, maternal education, and proteinuria
were not signiﬁcantly associated with hypospa-
dias risk in the final model. On the other
hand, the association with late-pregnancy nau-
sea became stronger and signiﬁcant after mul-
tiple adjustment. The association between low
consumption of meat and risk of hypospadias
was also stronger after adjustment.
Maternal characteristics. Boys born to over-
weight (prepregnancy BMI = 25–29) or obese
(prepregnancy BMI ≥ 30) women were 73%
and 162% more likely, respectively, to have
hypospadias than were boys born to women
with prepregnancy BMIs in the normal range
(BMI = 20–24) (adjusted ORs with 95% CIs
in Table 2); as maternal prepregnancy BMI
increased, the risk of hypospadias also increased
(p-value for trend = 0.0079).
Characteristics of the index pregnancy.
Maternal hypertension during pregnancy dou-
bled a boy’s risk of hypospadias (Table 2).
Compared with maternal nausea in the first
trimester, the absence of maternal nausea
during pregnancy almost doubled the risk of
hypospadias, whereas boys whose mothers
experienced nausea only in the third trimester
had a signiﬁcant 7-fold increased risk (Table 2).
Passive maternal exposure to tobacco smoke
during pregnancy increased the risk of hypospa-
dias by 88%. In contrast, active maternal smok-
ing in the ﬁrst trimester was not signiﬁcantly
associated with hypospadias risk.
Compared with a maternal diet that
included meat and/or ﬁsh, a diet lacking both
protein sources was associated with a more than
4-fold increased risk of hypospadias (Table 2).
When we examined meat and ﬁsh consump-
tion separately, boys whose mothers ate meat at
least once a week while pregnant were less likely
to have hypospadias than were boys whose
mothers never ate meat (OR = 0.42; 95% CI,
0.21–0.87). Compared with boys whose moth-
ers ate ﬁsh once or twice a week, those whose
mothers never (OR = 1.4; 95% CI, 0.84–2.2)
or rarely (OR = 2.7; 95% CI, 1.3–5.5) ate ﬁsh
were more likely to have hypospadias.
Characteristics of the child at birth. Being
small for gestational age (weight for gestational
age < 10th percentile) was strongly associated
with hypospadias risk, with the smallest boys
(< 2.5th percentile) being 4.4 (95% CI,
1.2–15) times as likely to have hypospadias as
boys in the 50th to 74th weight for gestational
age percentiles (Table 2). Being born preterm
(≤ 36 gestational weeks) was associated with a
9-fold increased risk of hypospadias, compared
with being born in gestational week 40 or 41
(Table 2).
Subgroup analyses. When we restricted
our analysis by excluding cases with cleaved
prepuce or glandular or coronary hypospadias
from the Stockholm clinic and their matched
controls, we obtained results similar to those
presented in Table 2, albeit with wider CIs
(data not shown).
Discussion
This study, one of the largest of its kind, had
several important ﬁndings. A pregnancy diet
lacking in meat and fish, a high maternal
prepregnancy BMI, and absence of nausea
during early pregnancy all independently
increased hypospadias risk.
Our maternal diet ﬁnding complements a
previously reported strong positive association
between maternal vegetarian diet and hypo-
spadias risk (North and Golding 2000). It has
previously been suggested that the risk of geni-
tal anomalies in male offspring may be
increased by intake of different soy proteins
frequently ingested by vegetarians. Soybeans
contain phytoestrogens that may produce
estrogenic as well as antiestrogenic effects via
the estrogen receptor (Rosselli et al. 2000). It
has been suggested that phytoestrogens from
soybeans, for instance, disrupt the masculin-
ization of the male through interference with
the pituitary–gonadal axis (Sharpe and
Skakkebaek 1993). Alternatively, however, the
exclusion of animal proteins could increase the
risk of a transient deﬁciency of some nutrient
essential during organogenesis or placentation.
Several authors have suggested that
hypospadias may be caused by abnormal levels
of pregnancy hormones resulting from
impaired placental function or exposure to dis-
ruptive exogenous hormones (Akre et al. 1999;
Czeizel et al. 1979; Klip et al. 2002). In partic-
ular, reduced levels of human chorionic
gonadotropin (hCG) have been suggested as a
candidate in the etiology of hypospadias
(Czeizel et al. 1979). hCG, which is produced
by the placenta and is chemically similar to
luteinizing hormone, is important to sexual
differentiation in the fetus and stimulates the
fetal testis before the fetus’s own pituitary–
gonadal axis is established. hCG has also been
shown to be an angiogenic factor during early
pregnancy (Zygmunt et al. 2002). As discussed
in more detail below, our ﬁndings of associa-
tions between an increased risk of hypospadias
and no maternal nausea during early preg-
nancy, low weight for gestational age, preterm
birth, gestational hypertension, and maternal
overweight may all potentially be explained by
impaired placental hormone production.
Nausea in early pregnancy is believed to be
caused by the early surge of pregnancy hor-
mones, particularly hCG; the onset and peak
of nausea and vomiting in early pregnancy
parallel the hCG curve (Furneaux et al. 2001;
Verberg et al. 2005). First-trimester nausea is
considered to be a sign of a healthy pregnancy,
because it is associated with lower risks of mis-
carriage and premature birth (Cnattingius
et al. 2000; Furneaux et al. 2001). In contrast,
the absence of nausea may reflect potential
problems with the pregnancy and is associated
with low hCG levels (Cnattingius et al. 2000;
Verberg et al. 2005). Our finding that the
absence of nausea during early pregnancy was
associated with increased hypospadias risk
therefore lends support to the hypothesis that
abnormally low hCG levels resulting from pla-
cental insufﬁciency in early pregnancy may be
involved in the etiology of hypospadias.
Carmichael et al. (2007) reported a similar
negative (but nonsignificant) association
between early nausea and hypospadias. Our
observation that nausea only during late preg-
nancy (“abnormal” nausea) was associated
with an increased risk of hypospadias is more
difﬁcult to explain, because the closing of the
urethral oriﬁce occurs early in pregnancy. The
finding was, however, based on few subjects
and may be spurious. On the other hand, lit-
tle is known about the mechanisms underly-
ing nausea in late pregnancy, but its etiology
is likely to differ from that of nausea in early
pregnancy, and it may reflect some process
initiated at the beginning of pregnancy that
has some bearing on the development of
hypospadias.
Risk factors for hypospadias
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tions between hypospadias risk and preterm
birth and low birth weight (Akre et al. 1999;
Aschim et al. 2004; Moller and Weidner
1999). Many authors have suggested that dis-
turbance of placental function early in preg-
nancy is a key mechanism underlying both
preterm birth/low birth weight and the
improper closure of the urethra, because the
placenta is the main producer of pregnancy
hormones in early pregnancy and is thus instru-
mental in the differentiation and development
of the fetal organs (Akre et al. 1999; Aschim
et al. 2004; Boisen et al. 2005; Hussain et al.
2002; Kallen 1988; Weidner et al. 1999). We,
too, found associations between hypospadias
risk and preterm birth (< 37 weeks gestation)
and/or being small for gestational age (< 10th
percentile). Our additional finding that
hypospadias risk is associated with gestational
hypertension, which in turn is associated with
preeclampsia and placental dysfunction (Ros
et al. 1998), has also previously been noted
(Aschim et al. 2004; Sorensen et al. 2005) and
provides further support for the notion that
placental dysfunction is involved in the etiol-
ogy of hypospadias.
Akre et al.
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Cases Controls
(n = 292) (n = 427)
Variable No. (%) No. (%) OR (95% CI)
Maternal characteristics
Age (years)
18–24 30 (10) 27 (6.3) 1.6 (0.88–2.8)
25–29 89 (31) 110 (26) 1.1 (0.78–1.7)
30–34 114 (39) 167 (39) 1
≥ 35 58 (20) 123 (29) 0.66 (0.44–1.00)
Height [cm (quartiles)]
≤ 163 78 (27) 97 (23) 1
164–167 65 (22) 103 (24) 0.77 (0.49–1.2)
168–171 72 (25) 111 (26) 0.80 (0.52–1.2)
≥ 172 76 (26) 115 (27) 0.82 (0.54–1.2)
BMI, prepregnancy (kg/m2)
≤ 19 49 (17) 71 (17) 1.3 (0.83–1.9)
20–24 151 (52) 257 (61) 1
25–29 58 (20) 70 (17) 1.6 (1.05–2.5)
≥ 30 32 (11) 22 (5) 2.7 (1.5–4.9)
Education (years)
≤ 9 42 (14) 46 (11) 1.5 (0.93–2.4)
10–12 120 (41) 155 (37) 1.2 (0.88–1.8)
≥ 13 129 (44) 222 (52) 1
Age at menarche (years)
9–12.5 97 (34) 151 (36) 1.05 (0.72–1.5)
13 91 (32) 143 (30) 1
13.5–19 94 (33) 127 (34) 1.2 (0.77–1.7)
History of irregular periods
No 205 (70) 289 (68) 1
Yes 87 (30) 138 (32) 0.89 (0.77–1.7)
Menstrual cycle length (days)
≤ 27 69 (25) 86 (21) 1.2 (0.82–1.7)
28–32 165 (61) 256 (64) 1
≥ 32 14 (5.2) 21 (5.2) 0.90 (0.42–1.9)
Irregular 24 (8.8) 39 (9.7) 0.95 (0.54–1.7)
Missinga 20 25
History of spontaneous abortion
No 225 (77) 315 (75) 1
1 49 (17) 76 (18) 0.96 (0.64–1.4)
2 14 (4.8) 18 (4.3) 1.2 (0.60–2.5)
≥ 3 3 (1.0) 13 (3.1) 0.30 (0.08–1.08)
History of stillbirth
No 289 (99) 417 (99) 1
Yes 2 (0.7) 4 (1.0) 0.94 (0.17–5.2)
Contraceptive use at conception
None 282 (97) 398 (94) 1
Combined oral contraceptivesb 3 (1.0) 3 (0.7) 1.6 (0.33–8.3)
Progestin-only oral contraceptives 2 (0.7) 2 (0.5) 1.9 (0.25–14)
Nonhormonal methodc 3 (1.0) 19 (4.5) 0.24 (0.07–0.81)
Time to index pregnancy (months)
< 6 187 (72) 244 (71) 1
6–12 29 (11) 51 (15) 0.71 (0.41–1.2)
> 12 45 (17) 51 (15) 1.1 (0.71–1.7)
Missinga 31 81
Characteristics of the index pregnancy
High blood pressure
No 236 (81) 392 (92) 1
Yes 55 (19) 35 (8.2) 2.8 (1.0–4.5)
Cases Controls
(n = 292) (n = 427)
Variable No. (%) No. (%) OR (95% CI)
Proteinuria
No 252 (87) 399 (93) 1
Yes 39 (13) 28 (6.6) 2.3 (1.4–3.9)
Nausea
No 131 (45) 141 (33) 1.9 (1.3–2.6)
Early pregnancy onlyd 132 (46) 254 (59) 1
Late pregnancy onlye 6 (2.1) 4 (0.9) 3.9 (0.94–17)
Early and late pregnancy 20 (6.9) 28 (6.6) 1.3 (0.70–2.6)
Fever, months 1–3
No 267 (91) 386 (91) 1
Yes 25 (8.6) 39 (9.2) 0.90 (0.53–1.5)
Weekly meat consumption
No 29 (10) 28 (6.6) 1.6 (0.9–2.7)
Yes 263 (90) 399 (93) 1
Weekly ﬁsh consumption
None 66 (23) 78 (18) 1.7 (1.1–2.5)
Less than once 70 (24) 60 (14) 2.5 (1.4–4.5)
Once or twice 149 (51) 269 (63) 1
More than twice 6 (2.1) 20 (4.7) 0.59 (0.23–1.5)
Weekly milk consumption
No 5 (1.7) 10 (2.4) 1
Yes 286 (98) 416 (98) 1.5 (0.50–4.4)
Diet without meat or ﬁsh
No 277 (95) 419 (98) 1
Yes 14 (4.8) 8 (1.9) 2.8 (1.2–6.7)
Daily cigarettes, months 1–3
None 249 (86) 361 (85) 1
1–10 33 (11) 56 (13) 0.80 (0.50–1.3)
> 10 9 (3.1) 10 (2.3) 1.5 (0.59–3.9)
Passive maternal exposure to tobacco smoke during index pregnancy
No 181 (62) 317 (74) 1
Yes 110 (38) 110 (26) 1.8 (1.2–2.6)
Characteristics of the child at birth
Birth order
1 109 (40) 138 (44) 1
2 107 (40) 164 (20) 0.94 (0.65–1.3)
≥ 3 54 (20) 75 (37) 0.86 (0.55–1.3)
Missinga 22 50
Weight for gestational age (percentile)
< 2.5 12 (4.1) 6 (1.4) 3.1 (1.09–15)
2.5–9.9 35 (12) 15 (3.5) 3.1 (1.6–5.3)
10.0–24.9 45 (15) 65 (15) 1.1 (0.67–1.9)
25.0–49.9 65 (22) 116 (27) 0.85 (0.55–1.4)
50.0–74.9 72 (25) 108 (25) 1
75.0–89.9 34 (12) 72 (17) 0.77 (0.45–1.3)
90.0–97.4 21 (7.2) 31 (7.3) 1.05 (0.55–2.0)
≥ 97.5 7 (2.4) 12 (2.8) 0.86 (0.32–2.4)
Gestational age at birth (weeks)
< 37 32 (11) 8 (1.9) 6.6 (2.9–15)
37–39 92 (32) 140 (33) 1.01 (0.72–1.4)
40–41 133 (46) 211 (50) 1
42–45 34 (12) 66 (16) 0.80 (0.50–1.3)
Neonatal jaundice
No 190 (66) 320 (75) 1
Yes 100 (34) 107 (25) 1.5 (1.07–2.2)
Table 1. Associations between hypospadias and selected maternal, pregnancy, and birth characteristics: unadjusted ORs from a matched case–control study,
Denmark and Sweden, 2000–2005.
aWe give the number of missing values for variables with information missing for more than 10 subjects. bEstrogen plus progestin. cNonhormonal IUD, condom, or rhythm method. dFirst 3
months of pregnancy. eLast 3 months of pregnancy.In the same vein, maternal overweight is
known to be associated with increased risks of
preeclampsia and late fetal death, possibly as a
consequence of vasoconstriction in the pla-
centa (Cnattingius et al. 1998; Eskenazi et al.
1991). In a recent study, Stewart et al. (2006)
reported that obese women have signiﬁcantly
lower plasma levels of plasminogen activator
inhibitor-2 (PAI-2) during the ﬁrst trimester
of pregnancy, but not thereafter. PAI-2, which
is part of the plasminogen activator system, is
derived from the functioning placenta and
thus a marker of placental function. The
authors concluded that their ﬁnding may pro-
vide a mechanistic link between obesity and
preeclampsia. The plasminogen activator sys-
tem is believed to be important in angiogene-
sis, and it has also been suggested to be
involved in the pathogenesis of congenital
malformations. In our data, we found an
increased risk of hypospadias among the off-
spring of overweight and obese women, with a
dose–response relationship between BMI and
hypospadias risk. It seems plausible that our
ﬁndings of increased risks of hypospadias asso-
ciated with both gestational hypertension and
obesity, despite their statistical independence,
share pathogenetic mechanisms, possibly
through their link to impairment of placental
function and growth during early pregnancy.
Our ﬁnding of increased risk associated with
maternal overweight is in accordance with
recent data from Carmichael et al. (2007).
Previous studies have yielded conflicting
results regarding parental smoking (preconcep-
tion and/or during pregnancy) and the risk of
hypospadias (Akre et al. 1999; Brouwers et al.
2007; Carmichael et al. 2005b; Pierik et al.
2004). We found an association between
hypospadias risk and exposure to passive smok-
ing, but no association with active maternal
smoking. Although there are mechanisms to
explain an association with paternal smoking
in the absence of an association with maternal
smoking—for example, smoking may cause
germline mutations—the most likely explana-
tion for the association with paternal smoking
is perhaps chance variability. The lack of asso-
ciation with active smoking could, however, be
partly explained by nondifferential under-
reporting driving the results toward the null.
Unfortunately, we lacked power to study
the potential role of hormonal contraception at
the time of conception. Those using non-
hormonal contraceptive methods such as con-
doms and “natural” methods had a signiﬁcantly
decreased OR for the risk hypospadias in the
crude analysis, but not in the multivariable
analysis. Nonhormonal contraceptive methods
per se are unlikely to be protective against
hypospadias, but women employing them
should have less exposure to exogenous hor-
mones in the period just before conception
than those who become pregnant immediately
after stopping oral contraceptive use or while
still using oral contraceptives.
Differences in case and control ascertain-
ment arose because of infrastructure differ-
ences between the countries and may raise
concerns about the validity of our study.
However, although different, study subject
ascertainment in each country was population
based and should have yielded nearly com-
plete ascertainment of cases in the relevant
geographic areas during the time periods in
question, along with a representative sample
of controls from those areas.
Case ascertainment in Sweden involved
examination by a pediatric urologist, thus
ensuring the specificity of the hypospadias
diagnosis among the Swedish cases. Two-thirds
of the cases in Denmark we identiﬁed through
nationwide registers, using ICD codes for
hypospadias. Because reimbursement of the
hospital depends on the reporting of these
diagnostic codes, little underreporting occurs,
although, of course, only detected cases will be
reported. Although the sensitivity of the
registers for the milder forms of hypospadias
may be low, registration of the more severe
Risk factors for hypospadias
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Table 2. Associations between hypospadias and maternal, pregnancy, and birth characteristics: adjusted ORs from multivariable modeling in a matched
case–control study, Denmark and Sweden, 2000–2005.a
aWe adjusted each OR for the other variables listed, except for contraceptive use at conception and proteinuria, which we added separately to the model. We introduced diet without
meat or ﬁsh as an alternative to the variables weekly meat/weekly ﬁsh consumption. bEstrogen plus progestin. cNonhormonal IUD, condom, or rhythm method. dFirst 3 months of preg-
nancy. eLast 3 months of pregnancy. 
p-Value
Variable  OR (95% CI) for trend
Maternal age (years)
18–24 1.1 (0.51–2.5)
25–29 1.3 (0.81–2.0)
30–34 1
≥ 35 0.62 (0.37–1.01) 0.06
Maternal BMI, preindex pregnancy
≤ 19 0.96 (0.55–1.6)
20–24 1
25–29 1.7 (1.02–3.0)
≥ 30 2.6 (1.2–5.7) 0.01
Maternal education (years)
≤ 9 1.4 (0.78–2.6)
10–12 1.05 (0.66–1.7)
≥ 13 1 0.56
Contraceptive use at conception
None 1
Combined oral contraceptivesb 1.3 (0.20–8.1)
Progestin-only oral contraceptives 1.3 (0.13–13)
Nonhormonal methodc 0.22 (0.04–1.3)
High maternal blood pressure, index pregnancy
No 1
Yes 2.0 (1.1–3.7)
Proteinuria
No 1
Yes 1.6 (0.85–3.2)
Maternal nausea, index pregnancy
No 1.8 (1.2–2.8)
Early pregnancy onlyd 1
Late pregnancy onlye 7.6 (1.09–53)
Early and late pregnancy 1.2 (0.54–2.8)
p-Value
Variable  OR (95% CI) for trend
Passive maternal exposure to tobacco smoke during index pregnancy
No 1
Yes 1.9 (1.2–3.0)
Weekly meat consumption
No 2.4 (1.1–4.9)
Yes 1
Weekly ﬁsh consumption
None 1.4 (0.84–2.2)
Less than once 2.7 (1.3–5.5)
Once or twice 1
More than twice 0.88 (0.31–2.5) 0.02
Maternal diet without meat or ﬁsh, index pregnancy
No 1
Yes 4.6 (1.56–13)
Weight for gestational age (percentile)
< 2.5 4.4 (1.2–16)
2.5–9.9 4.6 (2.0–10)
10.0–24.9 1.1 (0.61–2.1)
25.0–49.9 0.86 (0.51–1.5)
50.0–74.9 1
75.0–89.9 0.70 (0.36–1.4)
90.0–97.4 1.09 (0.50–2.4)
≥ 97.5 0.66 (0.19–2.3)
Gestational age at birth (weeks)
< 37 9.1 (3.3–25)
37–39 0.80 (0.53–1.2)
40–41 1
42–45 0.82 (0.46–1.5)
Neonatal jaundice
No 1
Yes 1.2 (0.79–1.9)hypospadias is probably fairly complete.
Furthermore, it is unlikely that boys are falsely
registered with the condition (high speciﬁcity
of the registers for hypospadias). The remain-
ing third of the cases from Denmark we identi-
fied based on information from the mother
herself. We find it unlikely that a woman
would have mistakenly stated that her son had
the condition. (There may, however, have been
underreporting of milder forms of the condi-
tion.) Therefore, we believe that the speciﬁcity
of our case ascertainment methods for the
diagnosis of hypospadias was high in Denmark
as well as in Sweden.
The sensitivity of our case ascertainment
methods is less important for the internal
validity of the study than for the generaliz-
ability of the results. Our case group may
have been skewed toward more severe cases
because of the requirement for confirmation
of the diagnosis by a pediatric urologist in
Sweden, the presumed tendency for registered
cases in Denmark to be more severe, and the
fact that we limited our case group to very
young boys (thereby possibly missing cases
detected at later ages). Because we enrolled
Swedish cases at a lower average age than the
Danish cases, the Swedish cases in particular
may be of somewhat higher grade. However,
when we restricted the analysis to Swedish
cases of known severity and focused on more
severe forms of hypospadias, we found no
indication of different etiologic patterns for
the severe cases that could indicate that our
results are not generalizable to less severe
cases, nor did we see any clear sign of a
dose–response relation between any exposure
and degree of hypospadias.
The response rate for Swedish case mothers
was exceptionally high (95%), because they
were approached in person in the clinics.
However, the response rates for Swedish con-
trol mothers and Danish case and control
mothers, whom we recruited by telephone,
were also very good (75–84%). Because the
response rates in all four groups were high, any
bias due to nonparticipation is likely to be neg-
ligible, and the chance of selection bias due to
differences in recruitment methods is minimal.
The use of self-administered questionnaires
may have introduced some misclassiﬁcation of
exposure; however, any such misclassiﬁcation
should not differ between cases and controls,
and any bias thus introduced should be in the
direction of the null. Bias due to differential
recall of exposure between cases and controls is
a well-known phenomenon in malformation
studies. However, because there are no well-
established etiologies for hypospadias, for most
exposures mothers of cases would have been
unlikely to systematically over- or underreport
their exposure status compared with control
mothers. In fact, the directions of some of our
associations are the opposite of what might
have been expected if recall bias had inﬂuenced
the results. For example, it is unlikely that lack
of nausea is perceived by laymen to be a prob-
lem, making it improbable that our ﬁnding of
an increased risk of hypospadias associated
with lack of nausea could be explained by dif-
ferential recall. Similarly, a vegetarian diet is
often considered part of a healthy lifestyle, and
associations between adverse outcomes and a
vegetarian diet are thus not likely to be a result
of recall bias.
In conclusion, consistent with a previous
hypothesis-generating study (North and
Golding 2000), we found a strongly increased
risk of hypospadias associated with a maternal
diet lacking in fish and meat. Furthermore,
we found positive associations between the
absence of nausea during pregnancy, maternal
hypertension, high BMI, and risk of hypospa-
dias. Most of these findings are compatible
with a role for placental insufficiency in the
etiology of hypospadias.
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